#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1260833	B	Inhibition of PHD1 by HTRF assay		8		single protein format	Scientific Literature
2.	ALA1260834	B	Inhibition of PHD2 at 1 mM by HTRF assay		6		single protein format	Scientific Literature
3.	ALA2034754	B	Binding affinity to Escherichia coli AlkB deltaN11 mutant assessed as change in melting temperature at 200 uM by differential scanning fluorimetry	Escherichia coli	26		assay format	Scientific Literature
4.	ALA2034755	B	Inhibition of Escherichia coli AlkB deltaN11 mutant using 5'-TTCmTTTTTTTTTTTT-3'-fluorescein as substrate after 4.5 mins by capillary electrophoresis-based laser-induced fluorescence assay	Escherichia coli	26		assay format	Scientific Literature
5.	ALA2344107	B	Inhibition of human hexahistidine-tagged full-length FTO expressed in Escherichia coli BL21 (DE3) using 3-methylthymidine as substrate assessed as inhibition of 3-methylthymidine conversion to thymidine after 1 hr by liquid chromatographic analysis	Homo sapiens	33		assay format	Scientific Literature
6.	ALA2344108	B	Inhibition of human hexahistidine-tagged full-length FTO expressed in Escherichia coli BL21 (DE3) assessed as residual activity at 200 uM by scintillation proximity assay	Homo sapiens	5		assay format	Scientific Literature
7.	ALA3301365	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Homo sapiens	1,614		cell-free format	AstraZeneca Deposited Data
8.	ALA3301366	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Rattus norvegicus	717		cell-free format	AstraZeneca Deposited Data
9.	ALA5216101	B	Inhibition of recombinant full length N-terminal hexahistidine-tagged human FTO demethylation activity expressed in Escherichia coli BL21 (DE3) incubated for 1 hrs using m3T nucleoside as substrate by LCMS-based assay	Homo sapiens	6		assay format	Scientific Literature
10.	ALA5229122	B	Inhibition of FTO (unknown origin)	Homo sapiens	18		single protein format	Scientific Literature
11.	ALA5229138	B	Inhibition of N-terminal truncated PHD2 (unknown origin) by luminescence based assay	Homo sapiens	1		single protein format	Scientific Literature